MitraClip in Patients with COPD: a Valid Option

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease are associated to hospitalization and mortality. 

MitraClip en el EPOC: una opción válida

When associated to severe mitral regurgitation, not only do these two conditions have poor evolution, but they also limit the possibility of surgical valve replacement, given its high risk. Edge-to-edge repair with MitraClip has been shown beneficial in a group of patients, but the information is quite limited. Only a few reports, such as the COAPT, have looked at data from this population. 

The study looked at 340 patients with severe mitral regurgitation undergoing edge to edge repair with MitraClip. 82 presented COPD (24.1%) defined by pulmonary function tests and GOLD criteria. 

From COPD patients, 26 showed GOLD stage 3 or 4 and the rest 2.

The groups were similar. Patients who did not present COPD were older. The ratio of men was higher in the COPD group. There were no differences in comorbidities. 

Read also: SOLACI-SOCIME 2022 | Rotablation in Superficial Femoral Angioplasty, by Dr. Alejandro Goldsmit.

25% presented primary mitral valve disease, ejection fraction was 40%, ORE was 36 mm2 with no differences in echocardiographic values. 

Procedural success was similar for both groups: COPD 97.4% vs. non-COPD 94.6% (p=0.27). Neither were there differences in mortality (4.9% vs. 5% p=0.95). In addition, mortality was similar between the GOLD COPD 3-4 vs non-COPD.

AT 30-day follow up, there were no differences in mortality, but there was a trend towards higher rehospitalization rate among COPD patients (12.9% vs. 6.8%, p = 0.08).

Read also: SOLACI-SOCIME 2022 | Neo commisural alignment and coronary overlap after TAVI, by Dr. Luis Nombela Franco.

At one year, there were no differences in mortality, but the was a trend towards increased one year mortality among COPD patients (31.2% vs. 20.6%, p = 0.06). There were no differences in rehospitalization for cardiac failure and both groups improved functional class, with no difference between them. 

There were no differences in the combined end point of mortality and rehospitalization for cardiac failure. 

Doppler echocardiogram at one year showed no differences in the presence of moderate or severe mitral regurgitation. 

Conclusion

COPD is highly prevalent among patients undergoing edge-to-edge for mitral valve repair. This strategy seems safe and effective in this group. COPD severity and impaired pulmonary function alone should not be considered a contraindication for edge-to-edge mitral valve repair. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Original: Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real‐world cohort.

Reference: Mhd Nawar Alachkar, et al. Catheter Cardiovasc Interv. 2022;100:145–153.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...